People · Operator

Kandaswamy Vijayan

Named in public records as an officer, director or promoter · active 2014–2021 · Biotechnology, Pharmaceuticals

2
Companies
2
Filings
$106.4M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Omniome, Inc.BiotechnologySeries C$100.2M$2.5B2014
Zafrens Inc.PharmaceuticalsSeries A$6.2M$97.6M2021
Operator network

Kandaswamy Vijayan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

CATHERINE S. LEE · 2 companies · 1 sharedCATHERINE S. LEEArnold S. Oliphant · 1 companies · 1 sharedArnold S. OliphantBoris S. Nikolic, M.D. · 1 companies · 1 sharedBoris S. Nikolic,…Dan S. Zabrowski · 1 companies · 1 sharedDan S. ZabrowskiDavid S. Cruikshank · 1 companies · 1 sharedDavid S. Cruiksha…David S. Mullarkey · 1 companies · 1 sharedDavid S. MullarkeyJohn S. Murphy, Ph.D. · 1 companies · 1 sharedJohn S. Murphy, P…Kelly S. Perez · 1 companies · 1 sharedKelly S. PerezKen S. Song, M.D., Ph.D. · 1 companies · 1 sharedKen S. Song, M.D.…Kim S. Kamdar, Ph.D. · 1 companies · 1 sharedKim S. Kamdar, Ph…Michael S. Yi · 1 companies · 1 sharedMichael S. YiMillard Y Chan · 1 companies · 1 sharedMillard Y ChanOmniome, Inc. · $100.2M raisedOmniome, Inc.Zafrens Inc. · $6.2M raisedZafrens Inc.Kandaswamy VijayanKV
Kandaswamy Vijayan Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Kandaswamy Vijayan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
CATHERINE S. LEE12
Dan S. Zabrowski11
Kim S. Kamdar, Ph.D.11
David S. Mullarkey11
Ken S. Song, M.D., Ph.D.11
Kelly S. Perez11
Arnold S. Oliphant11
David S. Cruikshank11
Michael S. Yi11
Boris S. Nikolic, M.D.11
Millard Y Chan11
John S. Murphy, Ph.D.11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.